摘要 |
The present invention relates to tricyclic quinoline and quinoxaline derivatives, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT2C receptor, and to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT2C receptor. |
申请人 |
ABBVIE DEUTSCHLAND GMBH & CO. KG;ABBVIE INC. |
发明人 |
KOOLMAN, HANNES;BRAJE, WILFRIED;MACK, HELMUT;HAUPT, ANDREAS;RELO, ANA LUCIA;DRESCHER, KARLA;BAKKER, MARGARETHA HENRICA MARIA;LAKICS, VIKTOR;HOFT, CAROLIN;XU, RUXU;ZHAO, XIAONA |